Clinical trial NCT04277286: Evaluation of the TRANSEND Program
Official title: Non-randomized Experimental Study Evaluating the Impact of Implantation of a New Organization in the Adult Sector Intended to Improve the Transition of Young People With Endocrine or Metabolic Diseases
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Pediatric Patient Transfer to Adult Service:Transition Program
Lead sponsor: Assistance Publique - Hôpitaux de Paris
Sponsor class: OTHER
First posted: 2020-02-20
Enrollment: 202
Sex: ALL
Minimum age (years): 18
Maximum age (years): 32
Standard ages: ADULT
Accepts healthy volunteers: no
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Young patients with endocrine or metabolic diseases

Brief summary: "Transend" is a program designed to promote the transition of young patients with endocrine or metabolic diseases when they arrive in the adult sector at La Pitié-Salpétrière hospital. The main objective of the study is to compare the rate of patients lost to follow-up at 24 months after the transfer of pediatrics between the Transend group and the (historical) control group.

Detailed description: Adolescence and early adulthood represent important periods for young people suffering from chronic diseases. Several observational studies show needs not covered by care services at this period and significant lost to follow-up rates. "Transend" is a program designed to promote the transition of young patients with endocrine or metabolic diseases when they arrive in the adult sector at La Pitié-Salpétrière hospital (Paris, France). Since September 1, 2016, approximately 500 patients benefited from it.

Eligibility criteria: Inclusion Criteria:

* Patient aged 18 to 32
* Patient with endocrine or metabolic disease
* Patient who had a follow-up in a pediatric department for his endocrine or metabolic disease
* Patient transferred to the adult sector in the endocrinology, metabolism or nutrition department of Pitié-Salpêtrière
* Patient who had a first post-transfer consultation between January 1, 2015 and September 1, 2017
* Patient with a social security protection

Exclusion Criteria:

* Patient who transferred to another adult service before being followed at Pitié-Salpêtrière
* Patient who has expressed his opposition to participate in this research

Primary outcomes:
measure: Rate of patients lost to follow-up at 24 months post transfert
timeFrame: 24 months post transfert
Secondary outcomes:
measure: Number of consultations not honored by the patient
timeFrame: 24 to 36 months post transfert
measure: Relationship of trust between caregiver and patient
timeFrame: 24 to 36 months post transfert
measure: Time to first consultation in adult medicine
timeFrame: 24 to 36 months post transfert
measure: Patient satisfaction
timeFrame: 24 to 36 months post transfet
measure: Avoided care consumption and associated costs
timeFrame: 24 to 36 months post transfret
measure: Compare the experience of the transition betmeen the two Groups
timeFrame: 24 to 36 months post transfret
measure: Assess Transend's efficiency
timeFrame: 24 to 36 months post transfret
Other outcomes:
Locations:
city: Paris
country: France
facility: Chef du Service d'Endocrinologie et Médecine de le Reproduction, Hôpital de la Pitié-Salpêtrière
Study officials:
affiliation: Assistance Publique - Hôpitaux de Paris
name: TOURAINE Philippe, PU-PH
role: PRINCIPAL_INVESTIGATOR
References: